These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 26319639)

  • 1. A protocol for assay of poly(lactide-co-glycolide) in clinical products.
    Garner J; Skidmore S; Park H; Park K; Choi S; Wang Y
    Int J Pharm; 2015 Nov; 495(1):87-92. PubMed ID: 26319639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodegradable poly(D, L-lactide-co-glycolide) (PLGA) microspheres for sustained release of risperidone: Zero-order release formulation.
    Su ZX; Shi YN; Teng LS; Li X; Wang LX; Meng QF; Teng LR; Li YX
    Pharm Dev Technol; 2011 Aug; 16(4):377-84. PubMed ID: 20370594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complex sameness: Separation of mixed poly(lactide-co-glycolide)s based on the lactide:glycolide ratio.
    Skidmore S; Hadar J; Garner J; Park H; Park K; Wang Y; Jiang XJ
    J Control Release; 2019 Apr; 300():174-184. PubMed ID: 30853529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microsphere delivery of Risperidone as an alternative to combination therapy.
    D'Souza S; Faraj J; DeLuca P
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated polymer biodegradation of risperidone poly(D, L-lactide-co-glycolide) microspheres.
    Selmin F; Blasi P; DeLuca PP
    AAPS PharmSciTech; 2012 Dec; 13(4):1465-72. PubMed ID: 23090111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Injectable, long-acting PLGA formulations: Analyzing PLGA and understanding microparticle formation.
    Park K; Skidmore S; Hadar J; Garner J; Park H; Otte A; Soh BK; Yoon G; Yu D; Yun Y; Lee BK; Jiang X; Wang Y
    J Control Release; 2019 Jun; 304():125-134. PubMed ID: 31071374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis.
    Duvvuri S; Janoria KG; Pal D; Mitra AK
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir.
    Duvvuri S; Janoria KG; Mitra AK
    J Control Release; 2005 Nov; 108(2-3):282-93. PubMed ID: 16229919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond Q1/Q2: The Impact of Manufacturing Conditions and Test Methods on Drug Release From PLGA-Based Microparticle Depot Formulations.
    Garner J; Skidmore S; Park H; Park K; Choi S; Wang Y
    J Pharm Sci; 2018 Jan; 107(1):353-361. PubMed ID: 29107048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of branched poly(lactide-co-glycolide) polymers used in injectable, long-acting formulations.
    Hadar J; Skidmore S; Garner J; Park H; Park K; Wang Y; Qin B; Jiang X
    J Control Release; 2019 Jun; 304():75-89. PubMed ID: 31054992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of lactide/glycolide ratio on the in vitro release of ganciclovir and its lipophilic prodrug (GCV-monobutyrate) from PLGA microspheres.
    Janoria KG; Mitra AK
    Int J Pharm; 2007 Jun; 338(1-2):133-41. PubMed ID: 17363204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of semi-solvent effects for PLGA polymers.
    Garner J; Skidmore S; Hadar J; Park H; Park K; Kuk Jhon Y; Qin B; Wang Y
    Int J Pharm; 2021 Jun; 602():120627. PubMed ID: 33915188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of exenatide in poly(D,L-lactide-co-glycolide) solutions: a simplified investigation on the peptide degradation by the polymer.
    Liang R; Zhang R; Li X; Wang A; Chen D; Sun K; Liu W; Li Y
    Eur J Pharm Sci; 2013 Nov; 50(3-4):502-10. PubMed ID: 23994054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of ONO-1301-loaded poly(lactide-co-glycolide) microspheres and their effect on nerve conduction velocity.
    Hazekawa M; Sakai Y; Yoshida M; Haraguchi T; Morisaki T; Uchida T
    J Pharm Pharmacol; 2011 Mar; 63(3):362-8. PubMed ID: 21749383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro-in vivo correlation of parenteral risperidone polymeric microspheres.
    Shen J; Choi S; Qu W; Wang Y; Burgess DJ
    J Control Release; 2015 Nov; 218():2-12. PubMed ID: 26423236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of chemically modified peptide from poly(D,L-lactide-co-glycolide) microspheres under in vitro release conditions.
    Murty SB; Goodman J; Thanoo BC; DeLuca PP
    AAPS PharmSciTech; 2003 Oct; 4(4):E50. PubMed ID: 15198545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation, characterization, and in vitro evaluation of physostigmine-loaded poly(ortho ester) and poly(ortho ester)/poly(D,L-lactide-co-glycolide) blend microspheres fabricated by spray drying.
    Wang L; Chaw CS; Yang YY; Moochhala SM; Zhao B; Ng S; Heller J
    Biomaterials; 2004 Jul; 25(16):3275-82. PubMed ID: 14980422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of uniform poly(d,l-lactide) and poly(d,l-lactide-co-glycolide) microspheres using a microfluidic chip for comparison.
    Yang CH; Huang KS; Grumezescu AM; Wang CY; Tzeng SC; Chen SY; Lin YH; Lin YS
    Electrophoresis; 2014 Feb; 35(2-3):316-22. PubMed ID: 23857679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of bases with different solubility on the release behavior of risperidone loaded PLGA microspheres.
    Hu Z; Liu Y; Yuan W; Wu F; Su J; Jin T
    Colloids Surf B Biointerfaces; 2011 Aug; 86(1):206-11. PubMed ID: 21524893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The angiogenic effect of ONO-1301, a novel long-acting prostacyclin agonist loaded in PLGA microspheres prepared using different molecular weights of PLGA, in a murine sponge model.
    Hazekawa M; Morihata K; Yoshida M; Sakai Y; Uchida T
    Drug Dev Ind Pharm; 2014 Nov; 40(11):1435-42. PubMed ID: 23937583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.